Report Detail
Global Dry Powder Inhaler Device Market Insights, Forecast to 2025
- RnM3061349 |
- 05 March, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
As a high tech industry, the manufacturing technology of Dry Powder Inhaler Device is mature but only these international giants can supply the high-end products with excellent performance. There is still a core technical barrier.
Today, the price of Dry Powder Inhaler Device is lower than past years. The reason for this downward trend of price is the development of technology and the price fluctuations of raw materials. In future, the price would go down continuously and slowly.
The global Dry Powder Inhaler Device market is valued at 640 million US$ in 2018 and will reach 900 million US$ by the end of 2025, growing at a CAGR of 4.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dry Powder Inhaler Device market based on company, product type, end user and key regions.
This report studies the global market size of Dry Powder Inhaler Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dry Powder Inhaler Device in these regions.
This research report categorizes the global Dry Powder Inhaler Device market by top players/brands, region, type and end user. This report also studies the global Dry Powder Inhaler Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Meda
Novartis
Schering/Merck
Teva
Vectura
Market size by Product
Single Dose
Multi-dose
Market size by End User
Asthma
COPD
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dry Powder Inhaler Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dry Powder Inhaler Device market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dry Powder Inhaler Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dry Powder Inhaler Device submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dry Powder Inhaler Device are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dry Powder Inhaler Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dry Powder Inhaler Device Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dry Powder Inhaler Device Market Size Growth Rate by Product
- 1.4.2 Single Dose
- 1.4.3 Multi-dose
- 1.5 Market by End User
- 1.5.1 Global Dry Powder Inhaler Device Market Size Growth Rate by End User
- 1.5.2 Asthma
- 1.5.3 COPD
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dry Powder Inhaler Device Market Size
- 2.1.1 Global Dry Powder Inhaler Device Revenue 2014-2025
- 2.1.2 Global Dry Powder Inhaler Device Sales 2014-2025
- 2.2 Dry Powder Inhaler Device Growth Rate by Regions
- 2.2.1 Global Dry Powder Inhaler Device Sales by Regions
- 2.2.2 Global Dry Powder Inhaler Device Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dry Powder Inhaler Device Sales by Manufacturers
- 3.1.1 Dry Powder Inhaler Device Sales by Manufacturers
- 3.1.2 Dry Powder Inhaler Device Sales Market Share by Manufacturers
- 3.1.3 Global Dry Powder Inhaler Device Market Concentration Ratio (CR5 and HHI)
- 3.2 Dry Powder Inhaler Device Revenue by Manufacturers
- 3.2.1 Dry Powder Inhaler Device Revenue by Manufacturers (2014-2019)
- 3.2.2 Dry Powder Inhaler Device Revenue Share by Manufacturers (2014-2019)
- 3.3 Dry Powder Inhaler Device Price by Manufacturers
- 3.4 Dry Powder Inhaler Device Manufacturing Base Distribution, Product Types
- 3.4.1 Dry Powder Inhaler Device Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dry Powder Inhaler Device Product Type
- 3.4.3 Date of International Manufacturers Enter into Dry Powder Inhaler Device Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dry Powder Inhaler Device Sales by Product
- 4.2 Global Dry Powder Inhaler Device Revenue by Product
- 4.3 Dry Powder Inhaler Device Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dry Powder Inhaler Device Breakdown Data by End User
6 North America
- 6.1 North America Dry Powder Inhaler Device by Countries
- 6.1.1 North America Dry Powder Inhaler Device Sales by Countries
- 6.1.2 North America Dry Powder Inhaler Device Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dry Powder Inhaler Device by Product
- 6.3 North America Dry Powder Inhaler Device by End User
7 Europe
- 7.1 Europe Dry Powder Inhaler Device by Countries
- 7.1.1 Europe Dry Powder Inhaler Device Sales by Countries
- 7.1.2 Europe Dry Powder Inhaler Device Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dry Powder Inhaler Device by Product
- 7.3 Europe Dry Powder Inhaler Device by End User
8 Asia Pacific
- 8.1 Asia Pacific Dry Powder Inhaler Device by Countries
- 8.1.1 Asia Pacific Dry Powder Inhaler Device Sales by Countries
- 8.1.2 Asia Pacific Dry Powder Inhaler Device Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dry Powder Inhaler Device by Product
- 8.3 Asia Pacific Dry Powder Inhaler Device by End User
9 Central & South America
- 9.1 Central & South America Dry Powder Inhaler Device by Countries
- 9.1.1 Central & South America Dry Powder Inhaler Device Sales by Countries
- 9.1.2 Central & South America Dry Powder Inhaler Device Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dry Powder Inhaler Device by Product
- 9.3 Central & South America Dry Powder Inhaler Device by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dry Powder Inhaler Device by Countries
- 10.1.1 Middle East and Africa Dry Powder Inhaler Device Sales by Countries
- 10.1.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dry Powder Inhaler Device by Product
- 10.3 Middle East and Africa Dry Powder Inhaler Device by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Dry Powder Inhaler Device Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AstraZeneca Dry Powder Inhaler Device Products Offered
- 11.2.5 AstraZeneca Recent Development
- 11.3 Boehringer Ingelheim
- 11.3.1 Boehringer Ingelheim Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Products Offered
- 11.3.5 Boehringer Ingelheim Recent Development
- 11.4 Chiesi
- 11.4.1 Chiesi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Chiesi Dry Powder Inhaler Device Products Offered
- 11.4.5 Chiesi Recent Development
- 11.5 Cipla
- 11.5.1 Cipla Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cipla Dry Powder Inhaler Device Products Offered
- 11.5.5 Cipla Recent Development
- 11.6 3M
- 11.6.1 3M Company Details
- 11.6.2 Company Business Overview
- 11.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 3M Dry Powder Inhaler Device Products Offered
- 11.6.5 3M Recent Development
- 11.7 Hovione
- 11.7.1 Hovione Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Hovione Dry Powder Inhaler Device Products Offered
- 11.7.5 Hovione Recent Development
- 11.8 Mannkind
- 11.8.1 Mannkind Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mannkind Dry Powder Inhaler Device Products Offered
- 11.8.5 Mannkind Recent Development
- 11.9 Meda
- 11.9.1 Meda Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Meda Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Meda Dry Powder Inhaler Device Products Offered
- 11.9.5 Meda Recent Development
- 11.10 Novartis
- 11.10.1 Novartis Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis Dry Powder Inhaler Device Products Offered
- 11.10.5 Novartis Recent Development
- 11.11 Schering/Merck
- 11.12 Teva
- 11.13 Vectura
12 Future Forecast
- 12.1 Dry Powder Inhaler Device Market Forecast by Regions
- 12.1.1 Global Dry Powder Inhaler Device Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dry Powder Inhaler Device Revenue Forecast by Regions 2019-2025
- 12.2 Dry Powder Inhaler Device Market Forecast by Product
- 12.2.1 Global Dry Powder Inhaler Device Sales Forecast by Product 2019-2025
- 12.2.2 Global Dry Powder Inhaler Device Revenue Forecast by Product 2019-2025
- 12.3 Dry Powder Inhaler Device Market Forecast by End User
- 12.4 North America Dry Powder Inhaler Device Forecast
- 12.5 Europe Dry Powder Inhaler Device Forecast
- 12.6 Asia Pacific Dry Powder Inhaler Device Forecast
- 12.7 Central & South America Dry Powder Inhaler Device Forecast
- 12.8 Middle East and Africa Dry Powder Inhaler Device Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dry Powder Inhaler Device Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dry Powder Inhaler Device . Industry analysis & Market Report on Dry Powder Inhaler Device is a syndicated market report, published as Global Dry Powder Inhaler Device Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dry Powder Inhaler Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
